TB-500 is a synthetic peptide that mirrors the actin-binding domain of Thymosin Beta-4, a ubiquitous intracellular protein integral to cytoskeletal dynamics and cellular repair signaling. In research settings, TB-500 is utilized as a functional surrogate for Thymosin Beta-4 to investigate G-actin sequestration, lamellipodia formation, and directional cell migration — phenomena relevant to tissue repair, regeneration, and inflammatory resolution.

Research examining TB-500 in cardiac models has reported effects on cardiomyocyte survival and cardiac progenitor cell activation following ischemic injury in rodent studies. Musculoskeletal research has investigated its effects on the repair of skeletal muscle tears, tendon injuries, and ligament damage, with studies reporting accelerated cellular repair processes and reduced fibrotic tissue deposition. TB-500 has also been investigated for its anti-inflammatory properties, including modulation of cytokine expression at injury sites in animal models.

TB-500 is widely referenced in regenerative biology, sports medicine research, and tissue engineering literature. Its well-characterized actin-binding mechanism and consistent activity across multiple tissue types make it a reliable research compound. This 10mg concentration is designed for extended research protocols, multi-tissue studies, or larger animal model applications.

Disclaimer: This product is intended for in vitro research and laboratory use only. It is not intended for human or veterinary use, consumption, or injection. Not approved by the FDA. Not intended to diagnose, treat, cure, or prevent any disease or medical condition. For use by qualified researchers only.